Detalhe da pesquisa
1.
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
N Engl J Med
; 380(7): 617-628, 2019 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30516102
2.
Changing frameworks in treatment sequencing of triple-negative and HER2-positive, early-stage breast cancers.
Lancet Oncol
; 20(7): e390-e396, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31267973
3.
The impact of communication style on patient satisfaction.
Breast Cancer Res Treat
; 176(2): 349-356, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31025271
4.
Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I-III HER2-positive breast cancer.
Breast Cancer Res Treat
; 169(2): 333-340, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29396664
5.
Co-targeting the HER and IGF/insulin receptor axis in breast cancer, with triple targeting with endocrine therapy for hormone-sensitive disease.
Breast Cancer Res Treat
; 163(1): 37-50, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28236033
6.
Association of LN Evaluation with Survival in Women Aged 70 Years or Older With Clinically Node-Negative Hormone Receptor Positive Breast Cancer.
Ann Surg Oncol
; 24(10): 3073-3081, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28766195
7.
Patient preferences regarding incidental genomic findings discovered during tumor profiling.
Cancer
; 122(10): 1588-97, 2016 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26970385
8.
Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States.
Cancer
; 121(15): 2544-52, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25902916
9.
Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors.
Cancer
; 121(11): 1817-26, 2015 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25649370
10.
In vitro and in vivo studies of the combination of IGF1R inhibitor figitumumab (CP-751,871) with HER2 inhibitors trastuzumab and neratinib.
Breast Cancer Res Treat
; 152(3): 533-44, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26195122
11.
Sirolimus and trastuzumab combination therapy for HER2-positive metastatic breast cancer after progression on prior trastuzumab therapy.
Breast Cancer Res Treat
; 150(1): 157-67, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25687356
12.
Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer.
Lab Invest
; 94(1): 98-106, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24189270
13.
Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases: Updated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial.
JAMA Oncol
; 9(2): 197-205, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36454580
14.
Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: induction of apoptosis by retinoid/trastuzumab combinations.
Breast Cancer Res
; 12(4): R62, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20696059
15.
Co-targeting the insulin-like growth factor I receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines.
Breast Cancer Res Treat
; 120(2): 327-35, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19337828
16.
Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2 (HER2)-Positive Breast Cancer.
JAMA Netw Open
; 3(11): e2027074, 2020 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33226431
17.
Acquired Resistance to HER2-Targeted Therapies Creates Vulnerability to ATP Synthase Inhibition.
Cancer Res
; 80(3): 524-535, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31690671
18.
Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial.
J Clin Oncol
; 38(23): 2610-2619, 2020 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32468955
19.
Preoperative chemotherapy decreases the need for re-excision of breast cancers between 2 and 4 cm diameter.
Ann Surg Oncol
; 16(3): 697-702, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19132447
20.
Carpal tunnel syndrome associated with the use of aromatase inhibitors in breast cancer.
Clin Breast Cancer
; 8(4): 362-5, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18757265